The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment
出版年份 2016 全文链接
标题
The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment
作者
关键词
-
出版物
LEUKEMIA
Volume 31, Issue 7, Pages 1570-1581
出版商
Springer Nature
发表日期
2016-11-28
DOI
10.1038/leu.2016.358
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multiple myeloma in the marrow: pathogenesis and treatments
- (2016) Heather Fairfield et al. Annals of the New York Academy of Sciences
- Advances in the pathogenesis and diagnosis of multiple myeloma
- (2015) M. Chesi et al. International Journal of Laboratory Hematology
- Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma
- (2015) Enrica Borsi et al. Translational Research
- Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells
- (2015) Rikio Suzuki et al. PLoS One
- The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells
- (2014) Bettina Grötsch et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Small Molecule Inhibitors Targeting Activator Protein 1 (AP-1)
- (2014) Na Ye et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance
- (2013) Z. Tian et al. BLOOD
- Targeting Mcl-1 for multiple myeloma (MM) therapy: Drug-induced generation of Mcl-1 fragment Mcl-1128–350 triggers MM cell death via c-Jun upregulation
- (2013) Fengjuan Fan et al. CANCER LETTERS
- HIF-1 of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
- (2013) R. Ria et al. CLINICAL CANCER RESEARCH
- Targeting transcription factors
- (2013) Jennifer E. Yeh et al. CURRENT OPINION IN ONCOLOGY
- A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
- (2013) Cory M. Johannessen et al. NATURE
- The role of tumour–stromal interactions in modifying drug response: challenges and opportunities
- (2013) Douglas W. McMillin et al. NATURE REVIEWS DRUG DISCOVERY
- Lack of BRAF V600E mutation in human myeloma cell lines established from myeloma patients with extramedullary disease
- (2013) L Lodé et al. Blood Cancer Journal
- A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
- (2012) Dharminder Chauhan et al. CANCER CELL
- The diverse roles of IRF4 in late germinal center B-cell differentiation
- (2012) Nilushi S. De Silva et al. IMMUNOLOGICAL REVIEWS
- Ets-1 Activates Overexpression of JunB and CD30 in Hodgkin's Lymphoma and Anaplastic Large-Cell Lymphoma
- (2011) Mariko Watanabe et al. AMERICAN JOURNAL OF PATHOLOGY
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Significant Biological Role of Sp1 Transactivation in Multiple Myeloma
- (2011) M. Fulciniti et al. CLINICAL CANCER RESEARCH
- JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma
- (2011) T Kanno et al. ONCOGENE
- A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression
- (2010) C. M. Annunziata et al. BLOOD
- Novel functions for NFκB: inhibition of bone formation
- (2010) Susan A. Krum et al. Nature Reviews Rheumatology
- A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effect
- (2009) Luca Agnelli et al. GENES CHROMOSOMES & CANCER
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now